Cardiovascular Aging Research & Development (CARD) Symposium

​The Cardiovascular Aging Research & Development (CARD) Symposium brings together leaders across biotechnology, medicine, and academia to discuss the next generation of cardiovascular therapeutics: from emerging clinical trials and precision cardiology to the molecular mechanisms driving cardiometabolic disease.

​We're excited to announce that John Maraganore (Founding CEO of Alnylam; Co-CEO of Corsera Health), Sekar Kathiresan (CEO of Verve Therapeutics; EVP at Eli Lilly), Michelle O'Donoghue (Brigham and Women's Hospital / TIMI Study Group), and Michael Davidson (CEO of NewAmsterdam Pharma) will be joining us as featured speakers at CARD.

​Scientific sessions will explore topics ranging from AI-driven cardiovascular data analysis and precision medicine to Lp(a)-targeted therapeutics, gene editing, cardiometabolic drug development, lipid biology, aldosterone dysregulation, vascular inflammation, and the translation of basic discoveries into new clinical therapies.

​Hosted by the Aging Initiative, CARD aims to bridge basic science, translational research, clinical medicine, and biotechnology to accelerate progress against cardiovascular disease, the world's leading cause of death.

​Registration approval is required to attend.

​Interested in sponsoring the symposium?

​Contact info@aging-initiative.org.